Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in patients with acromegaly: A clinicopathological study

Elif Tutku Durmuş, Ayşegül Atmaca, Mehmet Kefeli, Sultan Çalışkan, Özgür Mete, Kerim Aslan, Murat Fidan, Ramis Çolak, Buğra Durmuş